# PhoreMost Ltd: Biotechnology, Cambridge, United Kingdom

> PhoreMost Ltd: PhoreMost Ltd is a biotechnology and biopharmaceutical company based in Cambridge, UK. Based in Cambridge, United Kingdom. Founded 2014.

Source: https://millionrounds.com/startup/phoremost-ltd (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# PhoreMost Ltd

PhoreMost Ltd is a biotechnology and biopharmaceutical company based in Cambridge, UK.

Funding reported Last round: Series B

Biotechnology Cambridge, United Kingdom

Company summary

- **Founded:** 2014 12 years old
- **Team:** 31 11 to 50 people
- **Funding reported:** 64.1M as listed, currency not stated
- **Last round:** Series B Mar 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for PhoreMost Ltd has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About PhoreMost Ltd

PhoreMost Ltd is a biotechnology and biopharmaceutical company based in Cambridge, UK.

The company focuses on developing innovative cancer therapies by targeting "undruggable" disease sites. With roots as a Cambridge University spin-out, PhoreMost has established itself as a leader in drug discovery, emphasizing the identification of novel disease targets rather than repurposing existing ones. Its pipeline includes next-generation drug targets, particularly in oncology and inflammation. The company's proprietary phenotypic screening platform, SITESEEKER®, plays a crucial role in its research. This platform utilizes live-cell dynamics to discover hidden druggable target sites across the human genome, facilitating the rapid development of new small-molecule therapeutics. PhoreMost is advancing several key products, including PMC-001, aimed at treating brain cancers, and SOL686, a novel inhibitor for glioma. The company targets patients with high unmet clinical needs, including those with brain cancers and neurodegenerative disorders, while also collaborating with the biopharmaceutical and oncology research community.

## What company datasets say PhoreMost Ltd raised

Funding, as reported

Reported in all **64.1M** in the source's currency

Rounds **3**

Last round **Series B**

Last round size **11.8M**

Last round date **Mar 2021**

Investors listed **12**

## Founders and team

From PhoreMost Ltd's own website: 1 founder, 5 on the team.

**Chris Torrance** Founder / NED

- **Neil Torbett** CEO
- **Andrew Muncey** CFO
- **Rich Boyce** Senior VP
- **Barbara Duncan** Chair / NED
- **Simon Cook** SAB Chair

## The company, in detail

What they build

Known for

health care molecular glue activity glueseeker platform platform technology development information technology & services targeted therapy protein homeostasis hospital & health care surface-edited e3 ligase variants molecular glues design medical target validation health biotechnology target selectivity phenotypic screening platform

Built with from their website

Apache Viewport Meta Microsoft Exchange Microsoft 365 Apps & Services Mobile Friendly Open Graph Exclaimer GoDaddy Domains Microsoft Exchange Online Microsoft 365

+5 more

Apache HTTP Server Outlook Microsoft Email Providers GoDaddy Hosting Adobe Fonts

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** England
- **Revenue:** 1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/phoremost)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put PhoreMost Ltd in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)